Healthcare IT News October 23, 2020
Mike Miliard

“As these machines learn, we feel like there is going to be a change in expectation,” said Bakul Patel, director of the FDA’s Digital Health Center of Excellence.

At a virtual meeting of the U.S. Food and Drug Administration’s Center for Devices and Radiological Health and Patient Engagement Advisory Committee on Thursday, regulators offered updates and new discussion around medical devices and decision support powered by artificial intelligence.

One of the topics on the agenda was how to strike a balance between safety and innovation with algorithms getting smarter and better trained by the day.

In his discussion of AI and machine learning validation, Bakul Patel, director of the FDA’s recently-launched Digital Health Center of Excellence, said he sees huge...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Digital Health, FDA, Govt Agencies, Technology, Trends
Experts Aren’t Surprised About Optum Closing Its Virtual Care Business
Report: Apple and OpenAI Reopen iPhone AI Talks
Effectiveness of managing conditions with remote patient monitoring | Viewpoint
Designing for Health: Interview with Joyce Lee, MD
'Healthcare platform Doctolib has conquered France — but can it take on Europe?'

Share This Article